Quantitative Analysis and In vitro Anti-inflammatory Effects of Gallic Acid, Ellagic Acid, and Quercetin from Radix Sanguisorbae.
Level 5 - mechanism / opinion, no new human data
In vitro cell line study and analytical chemistry quantification.
PubMed 27076745 · doi:10.4103/0973-1296.177908
What was done
Researchers developed a reversed-phase high-performance liquid chromatography coupled with photodiode array detection (HPLC-PDA) method to quantify gallic acid, ellagic acid, and quercetin in an extract of Radix Sanguisorbae. They then evaluated the anti-inflammatory properties and cytotoxicity of these three isolated marker compounds in lipopolysaccharide (LPS)-stimulated murine macrophage cells (RAW 264.7), measuring prostaglandin E2 (PGE2), tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6).
What was found
Ellagic acid was the predominant marker component among those measured, quantified at 7.65 mg/g in the Radix Sanguisorbae extract. All three phytochemicals inhibited PGE2 production in LPS-stimulated RAW 264.7 macrophages without exhibiting cytotoxicity. Ellagic acid also significantly reduced the secretion of the proinflammatory cytokines TNF-alpha and IL-6, though exact numerical inhibition levels and concentrations for gallic acid and quercetin were not reported in the abstract.
Why it matters
This study provides an analytical method for quality control of Radix Sanguisorbae and identifies ellagic acid as a primary bioactive constituent contributing to its reported anti-inflammatory properties in vitro.
Limits
The study is restricted to in vitro testing in a murine cell line (RAW 264.7), lacking in vivo pharmacokinetic, bioavailability, or efficacy verification in animal models or humans. Specific concentrations, IC50 values, and numerical effect sizes for cytokine and PGE2 inhibition were omitted from the abstract.
Cited by
- supports In vitro studies show that applying ellagic acid or microbiome short-chain fatty acids to cultured inflammatory cells suppresses inflammatory activation.